(c) 2024 PillSync.com

zaleplon capsule

INDICATIONS AND USAGE Zaleplon Capsules are indicated for the short-term treatment of insomnia. Zaleplon Capsules have been shown to decrease the time to sleep onset for up to 30 days in controlled clinical studies (see CLINICAL PHARMACOLOGY , Clinical Trials ). They have not been shown to increase total sleep time or decrease the number of awakenings. The clinical trials performed in support of efficacy ranged from a single night to 5 weeks in duration. The final formal assessments of sleep latency were performed at the end of treatment.

teva pharmaceuticals usa inc


6 years ago CAPSULE BLUE 93 5269 zaleplon capsule

CAPSULE BLUE 93 5269

HOW SUPPLIED Zaleplon capsules, USP are available as: 5 mg - an opaque white body and opaque blue green cap, imprinted with “93” over “5268” on both the cap and the body in bottles of 100 (NDC 0093-5268-01). 10 mg - an opaque aqua blue body and opaque blue green cap, imprinted with “93” over “5269” on both the cap and the body in bottles of 100 (NDC 0093-5269-01). STORAGE CONDITIONS Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Croatia By: PLIVA HRVATSKA d.o.o. Zagreb, Croatia Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. G 8/2015


More pills like CAPSULE 93 5269












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site